Description
Explore the controversial world of peptide biohacking where thousands of men bypass traditional medical systems to self-administer gray-market compounds aimed at reversing aging, healing injuries, and altering body composition.
This episode follows Nelson Vergel and the Excel Mail community as they navigate evidence tiers, risks like endotoxin contamination and cancer concerns, and the shifting 2026 regulatory landscape — from secretagogues and tissue-repair peptides to GLP-1 weight-loss drugs and experimental mitochondrial therapies.